Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Leases (2019 - 2025)

Dexcom (DXCM) has disclosed Current Leases for 7 consecutive years, with $21.6 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 4.0% to $21.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.6 million through Dec 2025, down 4.0% year-over-year, with the annual reading at $21.6 million for FY2025, 4.0% down from the prior year.
  • Current Leases for Q4 2025 was $21.6 million at Dexcom, down from $23.6 million in the prior quarter.
  • The five-year high for Current Leases was $23.6 million in Q3 2025, with the low at $18.2 million in Q1 2021.
  • Average Current Leases over 5 years is $21.2 million, with a median of $21.2 million recorded in 2022.
  • The sharpest move saw Current Leases grew 25.52% in 2021, then fell 6.76% in 2024.
  • Over 5 years, Current Leases stood at $20.5 million in 2021, then changed by 0.0% to $20.5 million in 2022, then grew by 2.93% to $21.1 million in 2023, then grew by 6.64% to $22.5 million in 2024, then dropped by 4.0% to $21.6 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $21.6 million, $23.6 million, and $23.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.